https://www.targetedonc.com/view/breaking-down-resistance-to-btk-inhibitors
0
0
2/7/23 at 8:48pm
Organization
Targetedonc.com
Author
Skye Montoya
32 words
0
Comments
New research of the BTK degrader NX-2127 shows promising results for breaking down resistance to the therapy in the lymphoma and leukemia settings.
You are the first to view
Create an account
or login to join the discussion